Nicotine patch safe during pregnancy
This article was originally published in The Tan Sheet
Long-term nicotine replacement therapy advocated for pregnant women otherwise unable to stop smoking by Paul Ogburn, MD, State University of New York at Stony Brook, et al. Researchers found 22 mg/24 hrs of transdermal nicotine therapy administered for eight weeks did not affect gestational age, birth weight or "fetal well-being" in cohort of 21 pregnant smokers. Study was presented at Society for Maternal-Fetal Medicine's annual meeting in New Orleans Jan. 17 and published in December American Journal of Obstetrics & Gynecology. A California judge ruled last March against requiring that nonprescription NRT products carry labeling stating they "can harm your baby" (1"The Tan Sheet" March 26, 2001, p. 21)...
You may also be interested in...
Requiring a special California Proposition 65 pregnancy warning on OTC nicotine-containing smoking cessation patches and gums would conflict with FDA requirements, a San Francisco state court judge has ruled.
Amid a generally harsh environment, venture capital investors in South Korea appeared to take a more selective approach in 2022, with more established and financially stable domestic bioventures the biggest beneficiaries.
Sponsors want more endpoint clarity as current state of government pandemic response, along with scientific and regulatory hurdles, is constraining efforts to refill a shrinking COVID medicine cabinet and could create vulnerabilities for future pandemics.